SCHEMBL7149434

SCHEMBL7149434

CCCCSc1cc(-c2ccco2)nc(N)n1

nearest known ligand 0.47

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 13/20 0.45
ADORA1 P30542 13/20 0.45
ADORA3 P0DMS8 7/20 0.44
ADORA2B P29275 7/20 0.44
KMT2A Q03164 2/20 0.43
KDM4E B2RXH2 2/20 0.43
MEN1 O00255 1/20 0.43
ALDH1A1 P00352 1/20 0.43
MAPT P10636 1/20 0.43
BLM P54132 1/20 0.43
ABL1 P00519 1/20 0.42
RIN1 Q13671 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7151993 0.87 KDM4E (0.57) ADORA2AADORA1ADORA3ADORA2BKMT2A
SCHEMBL7151390 0.82 ADORA2A (0.55) ADORA2AADORA1ADORA3ADORA2BKMT2A
SCHEMBL7145784 0.79 KDM4E (0.54) ADORA2AADORA1ADORA3ADORA2BKMT2A
SCHEMBL7146168 0.78 ALDH1A1 (0.60) ADORA2AADORA1ADORA3ADORA2BKMT2A
SCHEMBL7147873 0.77 ADORA2A (0.57) ADORA2AADORA1ADORA3ADORA2BKMT2A
SCHEMBL1554000 0.75 MAPT (0.58) ADORA2AADORA1ADORA3ADORA2BKMT2A
SCHEMBL6623542 0.74 ADORA2A (0.67) ADORA2AADORA1ADORA3ADORA2B
SCHEMBL7152501 0.72 ADORA2A (0.43) ADORA2AADORA1ADORA3ADORA2BKMT2A
SCHEMBL30353595 0.71 ADORA2A (0.50) ADORA2AADORA1ADORA3ADORA2BKMT2A
SCHEMBL29044796 0.71 MAPT (0.53) ADORA2AADORA1ADORA3ADORA2BKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6586441-B2 2-Amino-6-benzylsulfanyl-4-thiophen-2-yl-pyridine-3,5-dicarbo -nitrile as an examplary preferred compound; Alzheimer's and Parkinson's diseases; neuroprotectors; schizophrenia, analgesics; anxiolytic agents; respiratory disorders HOFFMAN-LA ROCHE INC. 2003-07-01 US disclosed